- Home
- AURA vs TCMD Comparison
AURA vs TCMD Comparison
Compare AURA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- TCMD
- Stock Information
- Founded
- AURA 2007
- TCMD 1995
- Country
- AURA United States
- TCMD United States
- Employees
- AURA N/A
- TCMD N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- TCMD Medical/Dental Instruments
- Sector
- AURA Health Care
- TCMD Health Care
- Exchange
- AURA Nasdaq
- TCMD Nasdaq
- Market Cap
- AURA 390.0M
- TCMD 314.0M
- IPO Year
- AURA 2021
- TCMD 2016
- Fundamental
- Price
- AURA $6.00
- TCMD $9.97
- Analyst Decision
- AURA Strong Buy
- TCMD Hold
- Analyst Count
- AURA 6
- TCMD 3
- Target Price
- AURA $22.33
- TCMD $16.00
- AVG Volume (30 Days)
- AURA 191.8K
- TCMD 289.6K
- Earning Date
- AURA 08-07-2025
- TCMD 08-04-2025
- Dividend Yield
- AURA N/A
- TCMD N/A
- EPS Growth
- AURA N/A
- TCMD N/A
- EPS
- AURA N/A
- TCMD 0.66
- Revenue
- AURA N/A
- TCMD $293,164,000.00
- Revenue This Year
- AURA N/A
- TCMD $7.96
- Revenue Next Year
- AURA N/A
- TCMD $8.53
- P/E Ratio
- AURA N/A
- TCMD $15.10
- Revenue Growth
- AURA N/A
- TCMD 5.96
- 52 Week Low
- AURA $4.35
- TCMD $8.61
- 52 Week High
- AURA $12.38
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- AURA 47.06
- TCMD 41.97
- Support Level
- AURA $6.00
- TCMD $9.80
- Resistance Level
- AURA $6.45
- TCMD $10.67
- Average True Range (ATR)
- AURA 0.42
- TCMD 0.34
- MACD
- AURA -0.05
- TCMD 0.09
- Stochastic Oscillator
- AURA 14.39
- TCMD 19.54
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.